ADC Therapeutics S.A.

NYSE:ADCT

Biotechnology

Healthcare
$1.37 -1.35%

-$0.02 today

Market cap
$192.71M
Beta
1.77
P/E (TTM)
-1.2
EPS (TTM)
-$0.89
52W Low $0.78High $4.98

Volume 1.17M

Average 1.68M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$141.17M

FY 2025 · Annual

Investing Cash Flow

$395,000.00

FY 2025 · Annual

Financing Cash Flow

$150.94M

FY 2025 · Annual

+55.5% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(230.03M)(157.13M)(240.05M)(157.85M)(142.62M)
Depreciation & Amortization2.63M5.74M3.27M3.28M1.88M
Deferred Income Tax(26.05M)037.1M00
Stock-Based Compensation60.48M50.64M13.5M6.57M6.91M
Change in Working Capital(15.71M)(49.04M)44.27M3.83M(25.36M)
Accounts Receivables(30.22M)(42.75M)47.79M4.77M(8.79M)
Inventory(3.02M)(9.65M)(5.71M)(3.73M)(2.38M)
Accounts Payables6.8M310K3.17M2.46M(9.04M)
Other Working Capital10.73M3.37M(979K)321K(5.15M)
Other Non-Cash Items(24.7M)11.48M23.23M20.34M18.02M
Operating Cash Flow(233.38M)(138.31M)(118.69M)(123.84M)(141.17M)
Capital Expenditures(6.38M)(687K)(3.22M)(867K)(264K)
Acquisitions (Net)0000659K
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(3.24M)0000
Investing Cash Flow(6.67M)(687K)(3.22M)(867K)395K
Debt Repayment48.61M(2.71M)000
Common Stock Issued00060.51M152.46M
Common Stock Repurchased0(1.32M)000
Dividends Paid00000
Other Financing Activities218.78M3.13M73.88M36.55M(1.51M)
Financing Cash Flow267.39M(897K)73.88M97.05M150.95M
Effect of Forex Changes6K(208K)184K(83K)305K
Net Change in Cash27.35M(140.1M)(47.84M)(27.73M)10.47M
Free Cash Flow(239.75M)(139M)(121.9M)(124.7M)(141.44M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$142.6M
+ D&A$1.9M
+ Stock-Based Comp$6.9M
+ Deferred Tax$0
- Working Capital-$25.4M
+ Other Non-Cash$18.0M
= Operating Cash Flow-$141.2M
- Capex-$264.0K
= Free Cash Flow-$141.4M

Analysis

FY2025 free cash flow is -$141.4M. FCF conversion is 99.2% of net income. Operating cash flow was -$141.2M, with capex of -$264.0K. The largest bridge item is Working Capital at -$25.4M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
S-3S-3 filingNov 10, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
8-KCurrent reportNov 4, 2026

Does ADCT generate free cash flow?

ADC Therapeutics S.A. (ADCT) generated -$141.44M of free cash flow in fiscal 2025.

How much operating cash flow does ADCT produce?

Operating cash flow was -$141.17M, before capital expenditures of $264,000.00.